Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine (ERIEAS)
11. Oktober 2022 aktualisiert von: University Hospital, Bordeaux
The study is a realistic evaluation of the Expériences Animées school-based programme.
The aim is to precisely characterize i) the effects in terms of alcohol and cannabis consumption, the use of health professionals in case of problematic use of those two substances; ii) the context and underpinning mechanisms triggered by the program in terms of changes of alcohol and cannabis representations and life skills development.
This evaluation could allow to produce the key functions of the programme: how the intervention works, in which conditions.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
- Alcohol consumption represents the second main modifiable risk factor for cancer and the second preventable mortality cause in France, after tobacco use. It is mainly during adolescence, which corresponds to a period of integration with peers and a period of detachment from parents, that alcohol use starts. In France, alcohol remains the substance that adolescents most experiment with. A 2014 report shows that nearly half (49.4%) of first-year secondary school pupils have already tried an alcoholic drink and about one in seven secondary school pupils' reports having been drunk. The impact of cannabis consumption is wide as it can affect the social environment, the brain and the psychology of the consumers. Adolescence is a period during which the brain undergoes profound remodelling in areas that are high in cannabinoid receptors and that mediate cognitive control and emotion regulation. Therefore, childhood and adolescence are important stages of life on which preventive efforts may be focused, also because events occurring in the earliest stages of human development (before birth and during childhood) are known to be related to further risk for cancer, other chronic diseases and adult conditions.
- Among addiction prevention programmes, those that focus on life skills have been mentioned in the literature as being effective. In this context, the French organization "Association Ressources et Initiatives Addictions" (ARIA) has developed Expériences Animées programme (animated experiences) based on the above features, with the aim to help adolescents to change their representations and strengthen their life skills. This is a grassroots innovation. It has to be evaluated.
- The Expériences Animées programme involves supervised short movies and talks with secondary and high school pupils about the use of psychoactive substances. The movies are made specifically for the programme. The sessions are facilitated by two professionals including at least a clinical psychologist. In a given secondary/high school, one session per term is delivered for each class (40 classes). Three to five films are shown at each session. Each film aims to work on 2 to 3 life skills allowing to build protective behaviors against addictions. This programme is implemented since 2015.
- The investigators will collect quantitative and qualitative data to appraise the outcomes (O), mechanisms (M) and contextual elements (C), including the interventional elements) in order to verify the initial theories (hypothesis of causal pathways) by i) Questionnaires to collect outcomes in terms of consumption and health care, and some mechanisms: 2/ Non-directive interviews to collect mechanisms and contextual factors 3/ Observations to collect contextual elements during the sessions. The investigators will design the survey instruments in line with the initial middle-range theories identified.
Studientyp
Beobachtungs
Einschreibung (Tatsächlich)
1026
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
-
Bordeaux, Frankreich, 33000
- CIC1401-EC - CHU de Bordeaux Centre Inserm U1219
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Kind
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Probenahmeverfahren
Nicht-Wahrscheinlichkeitsprobe
Studienpopulation
Pupils from 10 secondary and hugh schools in the department of Charente (France)
Beschreibung
Inclusion Criteria:
Pupils :
- Pupils from the 10 secondary and high schools selected in the department of Charente, in 2nd and 5th years in 2019/2020 academic year,
- Pupils not opposite to participate and holders of parental authority not opposite to the participation of the child (no later than the day of inclusion)
Others :
- Non-opposition to participate of 3 Education professionals per establishment in the 10 secondary and high schools selected in the department of Charente,
- Non-opposition to participate of 2 session leaders,
- Non-opposition to participate of 3 funders.
Exclusion Criteria:
- Participants under legal protection
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: Sonstiges
- Zeitperspektiven: Interessent
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Expériences Animées Programme
The Expériences Animées programme involves supervised short movies and talks with secondary school and high school pupils about the use of psychoactive substances.
|
The questionnaires are completed at the 3 survey times (T0, T1 and T2) by all pupils involved.
Collected data are quantitative
The interviews are conducted with 80 pupils/year randomly selected (i.e. 2 per class and 8 per establishment/year).
Collected data are qualitative
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Daily, alcohol consumption
Zeitfenster: 3 years
|
Alcohol consumption per day at study entry, after 1 year and after 2 years
|
3 years
|
|
Weekly, alcohol consumption
Zeitfenster: 3 years
|
Alcohol consumption per week at study entry, after 1 year and after 2 years
|
3 years
|
|
Monthly, alcohol consumption
Zeitfenster: 3 years
|
Alcohol consumption per month at study entry, after 1 year and after 2 years
|
3 years
|
|
Number of episodes of heavy drinking
Zeitfenster: 3 years
|
An episode of heavy drinking : at least 5 drinks per occasion at study entry, after 1 year and after 2 years
|
3 years
|
|
Number of drunkenness episodes
Zeitfenster: 3 years
|
Number of episodes at study entry, after 1 year and after 2 years
|
3 years
|
|
Weekly, cannabis consumption
Zeitfenster: 3 years
|
Number of cannabis consumption per week at study entry, after 1 year and after 2 years
|
3 years
|
|
Monthly, cannabis consumption
Zeitfenster: 3 years
|
Number of cannabis consumption per month at study entry, after 1 year and after 2 years
|
3 years
|
|
Yearly, cannabis consumption
Zeitfenster: 3 years
|
Number of cannabis consumption per year at study entry, after 1 year and after 2 years
|
3 years
|
|
Number of consultation of a healthcare professional to discuss about a problematic use of alcohol and/or cannabis
Zeitfenster: 3 years
|
Number of times at study entry, after 1 year and after 2 years
|
3 years
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: François ALLA, MD PhD, CIC1401-EC, Inserm-CHU de Bordeaux
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
30. September 2019
Primärer Abschluss (Tatsächlich)
16. Juni 2022
Studienabschluss (Tatsächlich)
16. Juni 2022
Studienanmeldedaten
Zuerst eingereicht
26. September 2019
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
27. September 2019
Zuerst gepostet (Tatsächlich)
1. Oktober 2019
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
12. Oktober 2022
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
11. Oktober 2022
Zuletzt verifiziert
1. Oktober 2022
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- CHUBX 2018/75
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .